Management of asthma in childhood: study protocol of a systematic evidence update by the Paediatric Asthma in Real Life (PeARL) Think Tank

Alexander G Mathioudakis; Michael Miligkos; Cristina Boccabella; Gioulinta S Alimani; Adnan Custovic; A Deschildre; Francine Monique Ducharme; Omer Kalayci; Clare Murray; Antonio Nieto Garcia; Wanda Phipatanakul; David Price; Aziz Sheikh; Ioana Octavia Agache; Leonard Bacharier; Apostolos Beloukas; Andrew Bentley; Matteo Bonini; Jose A Castro-Rodriguez; Giuseppe De Carlo; Timothy Craig; Zuzana Diamant; Wojciech Feleszko; Tim Felton; James E Gern; Jonathan Grigg; Gunilla Hedlin; Elham M Hossny; Despo Ierodiakonou; Tuomas Jartti; Alan Kaplan; Robert F Lemanske; Peter N Le Souëf; Mika J Mäkelä; Georgios A Mathioudakis; Paolo Matricardi; Marina Mitrogiorgou; Mario Morais-Almeida; Karthik Nagaraju; Effie Papageorgiou; Helena Pité; Paulo M C Pitrez; Petr Pohunek; Graham Roberts; Ioanna Tsiligianni; Stephen Turner; Susanne Vijverberg; Tonya A Winders; Gary WK Wong; Paraskevi Xepapadaki; Heather J Zar; Nikolaos G Papadopoulos

doi:10.1136/bmjopen-2020-048338

Management of asthma in childhood: study protocol of a systematic evidence update by the Paediatric Asthma in Real Life (PeARL) Think Tank

Alexander G Mathioudakis
, Michael Miligkos
, Cristina Boccabella
, Gioulinta S Alimani
, Adnan Custovic
, A Deschildre
, Francine Monique Ducharme
, Omer Kalayci
, Clare Murray
, Antonio Nieto Garcia
, Wanda Phipatanakul
, David Price
, Aziz Sheikh
, Ioana Octavia Agache
, Leonard Bacharier
, Apostolos Beloukas
, Andrew Bentley
, Matteo Bonini
, Jose A Castro-Rodriguez
, Giuseppe De Carlo

Timothy Craig, Zuzana Diamant, Wojciech Feleszko, Tim Felton, James E Gern, Jonathan Grigg, Gunilla Hedlin, Elham M Hossny, Despo Ierodiakonou, Tuomas Jartti, Alan Kaplan, Robert F Lemanske, Peter N Le Souëf, Mika J Mäkelä, Georgios A Mathioudakis, Paolo Matricardi, Marina Mitrogiorgou, Mario Morais-Almeida, Karthik Nagaraju, Effie Papageorgiou, Helena Pité, Paulo M C Pitrez, Petr Pohunek, Graham Roberts, Ioanna Tsiligianni, Stephen Turner, Susanne Vijverberg, Tonya A Winders, Gary WK Wong, Paraskevi Xepapadaki, Heather J Zar, Nikolaos G Papadopoulos^* (Corresponding Author)

^*Corresponding author for this work

University of Manchester
University of Athens
Catholic University of the Sacred Heart
University of West Attica
Imperial College London
Hôpital Jeanne de Flandre
University of Montreal
Hacettepe Universitesi, Ankara
La Fe University and Polytechnic Hospital, Valencia
Boston Children's Hospital
University of Edinburgh
Transylvania University
University of Washington
Manchester University NHS Foundation Trust
Pontifical Universidad Catolica de Chile
European Federation of Pharmaceutical Industries and Associations
Pennsylvania State University
University of Groningen
Medical University of Warsaw
University of Wisconsin-Madison
Queen Mary University of London
Karolinska Institutet
Ain Shams University
University of Crete
University of Turku
University of Toronto
University of Western Australia
University of Helsinki
Athens Breath Centre
Charité – Universitätsmedizin Berlin
National and Kapodistrian University of Athens
Hospital CUF Descobertas, Lisboa
Allergy & Asthma, VN, Chennai
Pontifícia Universidade Católica do Rio Grande do Sul
Charles University Prague
University of Southampton
University of Amsterdam
Allergy & Asthma, Global Patient Platform, Virginia
The Chinese University of Hong Kong, Shenzhen
University of Cape Town

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

6 Downloads (Pure)

Abstract

Introduction Clinical recommendations for childhood asthma are often based on data extrapolated from studies conducted in adults, despite significant differences in mechanisms and response to treatments. The Paediatric Asthma in Real Life (PeARL) Think Tank aspires to develop recommendations based on the best available evidence from studies in children. An overview of systematic reviews (SRs) on paediatric asthma maintenance management and an SR of treatments for acute asthma attacks in children, requiring an emergency presentation with/without hospital admission will be conducted.Methods and analysis Standard methodology recommended by Cochrane will be followed. Maintenance pharmacotherapy of childhood asthma will be evaluated in an overview of SRs published after 2005 and including clinical trials or real-life studies. For evaluating pharmacotherapy of acute asthma attacks leading to an emergency presentation with/without hospital admission, we opted to conduct de novo synthesis in the absence of adequate up-to-date published SRs. For the SR of acute asthma pharmacotherapy, we will consider eligible SRs, clinical trials or real-life studies without time restrictions. Our evidence updates will be based on broad searches of Pubmed/Medline and the Cochrane Library. We will use A MeaSurement Tool to Assess systematic Reviews, V.2, Cochrane risk of bias 2 and REal Life EVidence AssessmeNt Tool to evaluate the methodological quality of SRs, controlled clinical trials and real-life studies, respectively.Next, we will further assess interventions for acute severe asthma attacks with positive clinical results in meta-analyses. We will include both controlled clinical trials and observational studies and will assess their quality using the previously mentioned tools. We will employ random effect models for conducting meta-analyses, and Grading of Recommendations Assessment, Development and Evaluation methodology to assess certainty in the body of evidence.Ethics and dissemination Ethics approval is not required for SRs. Our findings will be published in peer reviewed journals and will inform clinical recommendations being developed by the PeARL Think Tank.PROSPERO registration numbers CRD42020132990, CRD42020171624.

Original language	English
Article number	e048338
Number of pages	9
Journal	BMJ Open
Volume	11
Issue number	7
DOIs	https://doi.org/10.1136/bmjopen-2020-048338
Publication status	Published - 1 Jul 2021

Bibliographical note

Funding This work was supported by the Respiratory Effectiveness Group (REG). REG has received support from AstraZeneca, Novartis and Sanofi for continued work on PeARL. (Award/Grant name: PeARL, Award/Grant Number: N/A). This is an investigator initiated study and the funders were not involved in the selection of the topic, or design of these systematic reviews. AGM was supported by the National Institute for Health Research Manchester Biomedical Research Centre (NIHR Manchester BRC).
Acknowledgements AGM was supported by the National Institute of Health Research Manchester Biomedical Research Centre (NIHR Manchester BRC). We thank Mrs Maria Kritikou for excellent administrative support of the study

Access to Document

10.1136/bmjopen-2020-048338Licence: CC BY-NC

Mathioudakis_etal_Managment_of_Asthma_VOR
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Final published version, 399 KBLicence: CC BY-NC

Cite this

Mathioudakis, A. G., Miligkos, M., Boccabella, C., Alimani, G. S., Custovic, A., Deschildre, A., Ducharme, F. M., Kalayci, O., Murray, C., Garcia, A. N., Phipatanakul, W., Price, D., Sheikh, A., Agache, I. O., Bacharier, L., Beloukas, A., Bentley, A., Bonini, M., Castro-Rodriguez, J. A., ... Papadopoulos, N. G. (2021). Management of asthma in childhood: study protocol of a systematic evidence update by the Paediatric Asthma in Real Life (PeARL) Think Tank. BMJ Open, 11(7), Article e048338. https://doi.org/10.1136/bmjopen-2020-048338

Mathioudakis, AG, Miligkos, M, Boccabella, C, Alimani, GS, Custovic, A, Deschildre, A, Ducharme, FM, Kalayci, O, Murray, C, Garcia, AN, Phipatanakul, W, Price, D, Sheikh, A, Agache, IO, Bacharier, L, Beloukas, A, Bentley, A, Bonini, M, Castro-Rodriguez, JA, De Carlo, G, Craig, T, Diamant, Z, Feleszko, W, Felton, T, Gern, JE, Grigg, J, Hedlin, G, Hossny, EM, Ierodiakonou, D, Jartti, T, Kaplan, A, Lemanske, RF, Le Souëf, PN, Mäkelä, MJ, Mathioudakis, GA, Matricardi, P, Mitrogiorgou, M, Morais-Almeida, M, Nagaraju, K, Papageorgiou, E, Pité, H, Pitrez, PMC, Pohunek, P, Roberts, G, Tsiligianni, I, Turner, S, Vijverberg, S, Winders, TA, Wong, GWK, Xepapadaki, P, Zar, HJ & Papadopoulos, NG 2021, 'Management of asthma in childhood: study protocol of a systematic evidence update by the Paediatric Asthma in Real Life (PeARL) Think Tank', BMJ Open, vol. 11, no. 7, e048338. https://doi.org/10.1136/bmjopen-2020-048338

@article{374f6e21048948fa9218a5a51e8677ee,

title = "Management of asthma in childhood: study protocol of a systematic evidence update by the Paediatric Asthma in Real Life (PeARL) Think Tank",

abstract = "Introduction Clinical recommendations for childhood asthma are often based on data extrapolated from studies conducted in adults, despite significant differences in mechanisms and response to treatments. The Paediatric Asthma in Real Life (PeARL) Think Tank aspires to develop recommendations based on the best available evidence from studies in children. An overview of systematic reviews (SRs) on paediatric asthma maintenance management and an SR of treatments for acute asthma attacks in children, requiring an emergency presentation with/without hospital admission will be conducted.Methods and analysis Standard methodology recommended by Cochrane will be followed. Maintenance pharmacotherapy of childhood asthma will be evaluated in an overview of SRs published after 2005 and including clinical trials or real-life studies. For evaluating pharmacotherapy of acute asthma attacks leading to an emergency presentation with/without hospital admission, we opted to conduct de novo synthesis in the absence of adequate up-to-date published SRs. For the SR of acute asthma pharmacotherapy, we will consider eligible SRs, clinical trials or real-life studies without time restrictions. Our evidence updates will be based on broad searches of Pubmed/Medline and the Cochrane Library. We will use A MeaSurement Tool to Assess systematic Reviews, V.2, Cochrane risk of bias 2 and REal Life EVidence AssessmeNt Tool to evaluate the methodological quality of SRs, controlled clinical trials and real-life studies, respectively.Next, we will further assess interventions for acute severe asthma attacks with positive clinical results in meta-analyses. We will include both controlled clinical trials and observational studies and will assess their quality using the previously mentioned tools. We will employ random effect models for conducting meta-analyses, and Grading of Recommendations Assessment, Development and Evaluation methodology to assess certainty in the body of evidence.Ethics and dissemination Ethics approval is not required for SRs. Our findings will be published in peer reviewed journals and will inform clinical recommendations being developed by the PeARL Think Tank.PROSPERO registration numbers CRD42020132990, CRD42020171624.",

author = "Mathioudakis, \{Alexander G\} and Michael Miligkos and Cristina Boccabella and Alimani, \{Gioulinta S\} and Adnan Custovic and A Deschildre and Ducharme, \{Francine Monique\} and Omer Kalayci and Clare Murray and Garcia, \{Antonio Nieto\} and Wanda Phipatanakul and David Price and Aziz Sheikh and Agache, \{Ioana Octavia\} and Leonard Bacharier and Apostolos Beloukas and Andrew Bentley and Matteo Bonini and Castro-Rodriguez, \{Jose A\} and \{De Carlo\}, Giuseppe and Timothy Craig and Zuzana Diamant and Wojciech Feleszko and Tim Felton and Gern, \{James E\} and Jonathan Grigg and Gunilla Hedlin and Hossny, \{Elham M\} and Despo Ierodiakonou and Tuomas Jartti and Alan Kaplan and Lemanske, \{Robert F\} and \{Le Sou{\"e}f\}, \{Peter N\} and M{\"a}kel{\"a}, \{Mika J\} and Mathioudakis, \{Georgios A\} and Paolo Matricardi and Marina Mitrogiorgou and Mario Morais-Almeida and Karthik Nagaraju and Effie Papageorgiou and Helena Pit{\'e} and Pitrez, \{Paulo M C\} and Petr Pohunek and Graham Roberts and Ioanna Tsiligianni and Stephen Turner and Susanne Vijverberg and Winders, \{Tonya A\} and Wong, \{Gary WK\} and Paraskevi Xepapadaki and Zar, \{Heather J\} and Papadopoulos, \{Nikolaos G\}",

note = "Funding This work was supported by the Respiratory Effectiveness Group (REG). REG has received support from AstraZeneca, Novartis and Sanofi for continued work on PeARL. (Award/Grant name: PeARL, Award/Grant Number: N/A). This is an investigator initiated study and the funders were not involved in the selection of the topic, or design of these systematic reviews. AGM was supported by the National Institute for Health Research Manchester Biomedical Research Centre (NIHR Manchester BRC). Acknowledgements AGM was supported by the National Institute of Health Research Manchester Biomedical Research Centre (NIHR Manchester BRC). We thank Mrs Maria Kritikou for excellent administrative support of the study",

year = "2021",

month = jul,

day = "1",

doi = "10.1136/bmjopen-2020-048338",

language = "English",

volume = "11",

journal = "BMJ Open",

issn = "2044-6055",

publisher = "BMJ Publishing Group",

number = "7",

}

TY - JOUR

T1 - Management of asthma in childhood

T2 - study protocol of a systematic evidence update by the Paediatric Asthma in Real Life (PeARL) Think Tank

AU - Mathioudakis, Alexander G

AU - Miligkos, Michael

AU - Boccabella, Cristina

AU - Alimani, Gioulinta S

AU - Custovic, Adnan

AU - Deschildre, A

AU - Ducharme, Francine Monique

AU - Kalayci, Omer

AU - Murray, Clare

AU - Garcia, Antonio Nieto

AU - Phipatanakul, Wanda

AU - Price, David

AU - Sheikh, Aziz

AU - Agache, Ioana Octavia

AU - Bacharier, Leonard

AU - Beloukas, Apostolos

AU - Bentley, Andrew

AU - Bonini, Matteo

AU - Castro-Rodriguez, Jose A

AU - De Carlo, Giuseppe

AU - Craig, Timothy

AU - Diamant, Zuzana

AU - Feleszko, Wojciech

AU - Felton, Tim

AU - Gern, James E

AU - Grigg, Jonathan

AU - Hedlin, Gunilla

AU - Hossny, Elham M

AU - Ierodiakonou, Despo

AU - Jartti, Tuomas

AU - Kaplan, Alan

AU - Lemanske, Robert F

AU - Le Souëf, Peter N

AU - Mäkelä, Mika J

AU - Mathioudakis, Georgios A

AU - Matricardi, Paolo

AU - Mitrogiorgou, Marina

AU - Morais-Almeida, Mario

AU - Nagaraju, Karthik

AU - Papageorgiou, Effie

AU - Pité, Helena

AU - Pitrez, Paulo M C

AU - Pohunek, Petr

AU - Roberts, Graham

AU - Tsiligianni, Ioanna

AU - Turner, Stephen

AU - Vijverberg, Susanne

AU - Winders, Tonya A

AU - Wong, Gary WK

AU - Xepapadaki, Paraskevi

AU - Zar, Heather J

AU - Papadopoulos, Nikolaos G

N1 - Funding This work was supported by the Respiratory Effectiveness Group (REG). REG has received support from AstraZeneca, Novartis and Sanofi for continued work on PeARL. (Award/Grant name: PeARL, Award/Grant Number: N/A). This is an investigator initiated study and the funders were not involved in the selection of the topic, or design of these systematic reviews. AGM was supported by the National Institute for Health Research Manchester Biomedical Research Centre (NIHR Manchester BRC). Acknowledgements AGM was supported by the National Institute of Health Research Manchester Biomedical Research Centre (NIHR Manchester BRC). We thank Mrs Maria Kritikou for excellent administrative support of the study

PY - 2021/7/1

Y1 - 2021/7/1

N2 - Introduction Clinical recommendations for childhood asthma are often based on data extrapolated from studies conducted in adults, despite significant differences in mechanisms and response to treatments. The Paediatric Asthma in Real Life (PeARL) Think Tank aspires to develop recommendations based on the best available evidence from studies in children. An overview of systematic reviews (SRs) on paediatric asthma maintenance management and an SR of treatments for acute asthma attacks in children, requiring an emergency presentation with/without hospital admission will be conducted.Methods and analysis Standard methodology recommended by Cochrane will be followed. Maintenance pharmacotherapy of childhood asthma will be evaluated in an overview of SRs published after 2005 and including clinical trials or real-life studies. For evaluating pharmacotherapy of acute asthma attacks leading to an emergency presentation with/without hospital admission, we opted to conduct de novo synthesis in the absence of adequate up-to-date published SRs. For the SR of acute asthma pharmacotherapy, we will consider eligible SRs, clinical trials or real-life studies without time restrictions. Our evidence updates will be based on broad searches of Pubmed/Medline and the Cochrane Library. We will use A MeaSurement Tool to Assess systematic Reviews, V.2, Cochrane risk of bias 2 and REal Life EVidence AssessmeNt Tool to evaluate the methodological quality of SRs, controlled clinical trials and real-life studies, respectively.Next, we will further assess interventions for acute severe asthma attacks with positive clinical results in meta-analyses. We will include both controlled clinical trials and observational studies and will assess their quality using the previously mentioned tools. We will employ random effect models for conducting meta-analyses, and Grading of Recommendations Assessment, Development and Evaluation methodology to assess certainty in the body of evidence.Ethics and dissemination Ethics approval is not required for SRs. Our findings will be published in peer reviewed journals and will inform clinical recommendations being developed by the PeARL Think Tank.PROSPERO registration numbers CRD42020132990, CRD42020171624.

AB - Introduction Clinical recommendations for childhood asthma are often based on data extrapolated from studies conducted in adults, despite significant differences in mechanisms and response to treatments. The Paediatric Asthma in Real Life (PeARL) Think Tank aspires to develop recommendations based on the best available evidence from studies in children. An overview of systematic reviews (SRs) on paediatric asthma maintenance management and an SR of treatments for acute asthma attacks in children, requiring an emergency presentation with/without hospital admission will be conducted.Methods and analysis Standard methodology recommended by Cochrane will be followed. Maintenance pharmacotherapy of childhood asthma will be evaluated in an overview of SRs published after 2005 and including clinical trials or real-life studies. For evaluating pharmacotherapy of acute asthma attacks leading to an emergency presentation with/without hospital admission, we opted to conduct de novo synthesis in the absence of adequate up-to-date published SRs. For the SR of acute asthma pharmacotherapy, we will consider eligible SRs, clinical trials or real-life studies without time restrictions. Our evidence updates will be based on broad searches of Pubmed/Medline and the Cochrane Library. We will use A MeaSurement Tool to Assess systematic Reviews, V.2, Cochrane risk of bias 2 and REal Life EVidence AssessmeNt Tool to evaluate the methodological quality of SRs, controlled clinical trials and real-life studies, respectively.Next, we will further assess interventions for acute severe asthma attacks with positive clinical results in meta-analyses. We will include both controlled clinical trials and observational studies and will assess their quality using the previously mentioned tools. We will employ random effect models for conducting meta-analyses, and Grading of Recommendations Assessment, Development and Evaluation methodology to assess certainty in the body of evidence.Ethics and dissemination Ethics approval is not required for SRs. Our findings will be published in peer reviewed journals and will inform clinical recommendations being developed by the PeARL Think Tank.PROSPERO registration numbers CRD42020132990, CRD42020171624.

U2 - 10.1136/bmjopen-2020-048338

DO - 10.1136/bmjopen-2020-048338

M3 - Article

SN - 2044-6055

VL - 11

JO - BMJ Open

JF - BMJ Open

IS - 7

M1 - e048338

ER -

Management of asthma in childhood: study protocol of a systematic evidence update by the Paediatric Asthma in Real Life (PeARL) Think Tank

Abstract

Bibliographical note

Access to Document

Fingerprint

Cite this